Background Image
Table of Contents Table of Contents
Previous Page  156 / 1498 Next Page
Information
Show Menu
Previous Page 156 / 1498 Next Page
Page Background

Bendamustine in Rituximab refractory FL

Kahl BS, et al.

Cancer.

2010;116(1):106-114.

100 patients rituximab refractory

Bendamustine: 120 mg/m

2

ORR: 75%

CR: 14%

Median PFS: 9 months